CONMED Corporation Adds Mark Kaye to its Board of Directors
CONMED Corporation (
NYSECNMD) today announced that Mark Kaye will be joining its Board of Directors effective February 24th, 2025.
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (
NYSECNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on February 24, 2025, payable on April 4, 2025, to all shareholders of record as of March 14, 2025.
CONMED Corporation Announces Fourth Quarter and Full-Year 2024 Financial Results
CONMED Corporation (
NYSECNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2024.
CONMED Corporation to Announce Fourth Quarter 2024 Financial Results on February 5, 2025
CONMED Corporation (
NYSECNMD) today announced that it will report financial results for the fourth quarter 2024 after the market close on Wednesday, February 5, 2025. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
CONMED Corporation to Present at the J.P. Morgan Healthcare Conference
CONMED Corporation (
NYSECNMD) today announced that Patrick J. Beyer, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the J.P. Morgan Healthcare Conference at 4:30 p.m. PT (7:30 p.m. ET) on Monday, January 13, 2025 in San Francisco, CA.
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (
NYSECNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on December 9, 2024, payable on January 3, 2025, to all shareholders of record as of December 20, 2024.
CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference
CONMED Corporation (
NYSECNMD) today announced that Curt R. Hartman, President and Chief Executive Officer, Todd W. Garner, Executive Vice President and Chief Financial Officer, and Pat J. Beyer, Chief Operating Officer, will participate in a fireside chat at the Piper Sandler Healthcare Conference at 12:30 p.m. ET on Tuesday, December 3, 2024.
CONMED Corporation to Participate in Fireside Chats at Two Investor Conferences on November 19-20
CONMED Corporation (
NYSECNMD) today announced that it will participate in fireside chats at the following two investor conferences in November:
CONMED Corporation Announces Third Quarter 2024 Financial Results
CONMED Corporation (
NYSECNMD) today announced financial results for the third quarter ended September 30, 2024.
CONMED Corporation Announces Leadership Succession
CONMED Corporation (
NYSECNMD) today announced that Curt R. Hartman will retire as President and Chief Executive Officer (CEO) of the Company, effective January 1, 2025. Patrick Beyer, current Chief Operating Officer (COO) of CONMED, will succeed Mr. Hartman as President and CEO and will also be appointed as a member of the Company’s board, effective the same date.
CONMED Corporation Announces Preliminary Third Quarter Financial Information
As a follow up to the Current Report on Form 8-K issued by the Company on September 30, 2024, CONMED Corporation (
NYSECNMD) announced preliminary financial information for the third quarter of 2024. The Company expects revenue in the range of $315 million to $318 million and adjusted diluted net earnings per share growth in excess of its previously provided guidance of 9% to 11%.
CONMED Corporation to Participate in a Virtual Fireside Chat at the CL King Best Ideas Conference
CONMED Corporation (
NYSECNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at the CL King 22nd Annual Best Ideas Conference at 10:15 a.m. ET on Monday, September 16, 2024.
CONMED Corporation to Participate in a Fireside Chat at the Wells Fargo Healthcare Conference
CONMED Corporation (
NYSECNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Wells Fargo Healthcare Conference at 8:00 a.m. ET on Wednesday, September 4, 2024.
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (
NYSECNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on August 8, 2024, payable on October 4, 2024, to all shareholders of record as of September 16, 2024.
CONMED Corporation Announces Second Quarter 2024 Financial Results
CONMED Corporation (
NYSECNMD) today announced financial results for the second quarter ended June 30, 2024.
CONMED Corporation to Announce Second Quarter 2024 Financial Results on July 31, 2024
CONMED Corporation (
NYSECNMD) today announced it will report financial results for the second quarter of 2024 after the market close on Wednesday, July 31, 2024. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
CONMED Corporation to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference
CONMED Corporation (
NYSECNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference at 8:00 a.m. ET on Thursday, June 6, 2024.
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (
NYSECNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on May 22, 2024, payable on July 5, 2024, to all shareholders of record as of June 14, 2024.
CONMED Corporation to Present at the BofA Securities Healthcare Conference
CONMED Corporation (
NYSECNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, Todd W. Garner, Executive Vice President and Chief Financial Officer, and Pat Beyer, Chief Operating Officer, will present at the BofA Securities Healthcare Conference at 2:20 p.m. PT (5:20 p.m. ET) on Tuesday, May 14, 2024 in Las Vegas, NV.
CONMED Corporation Promotes Patrick Beyer to Chief Operating Officer
CONMED Corporation (
NYSECNMD) today announced that Patrick Beyer, President of International and Global Orthopedics, has been promoted to the newly created role of Chief Operating Officer (COO), effective immediately. In this role, Mr. Beyer will take on additional responsibility for leading the Company’s commercial businesses, as well as Operations, Distribution, Regulatory Affairs / Quality Assurance, and Customer Excellence.
CONMED Corporation Announces First Quarter 2024 Financial Results
CONMED Corporation (
NYSECNMD) today announced financial results for the first quarter ended March 31, 2024.
CONMED Corporation to Announce First Quarter 2024 Financial Results on April 24, 2024
CONMED Corporation (
NYSECNMD) today announced that it will report financial results for the first quarter 2024 after the market close on Wednesday, April 24, 2024. The Company’s management will host a conference call at 4:30 p.m. ET that same day to discuss the results.
CONMED Corporation Announces Quarterly Cash Dividend
CONMED Corporation (
NYSECNMD) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on February 26, 2024, payable on April 5, 2024, to all shareholders of record as of March 15, 2024.
CONMED Corporation Announces Fourth Quarter and Full-Year 2023 Financial Results
CONMED Corporation (
NYSECNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2023.
Med-tech stock Conmed dips ahead of big Q4 report...opportunity?Currently in the mid-$90’s, CONMED itself is in need of some restorative surgery - and this week’s earnings release could be the first step.
